Omics International Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 4.90 Cr
as on 11-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
as on 11-12-2024
- Satisfied Charges ₹ 90.25 Cr
as on 11-12-2024
- Revenue -33.96%
(FY 2021)
- Profit -5.26%
(FY 2021)
- Ebitda 89.12%
(FY 2021)
- Net Worth 1.93%
(FY 2021)
- Total Assets -1.18%
(FY 2021)
About Omics International
The Corporate was formerly known as Omics Online Publishing Private Limited. The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.90 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹90.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gedela Rao and Anitha Gedela serve as directors at the Company.
- CIN/LLPIN
U22122TG2008PTC061143
- Company No.
061143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Omics International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gedela Rao  | Director | 30-Sep-2019 | Current |
| Anitha Gedela | Director | 20-Jan-2016 | Current |
Financial Performance of Omics International.
Omics International Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 33.96% decrease. The company also saw a slight decrease in profitability, with a 5.26% decrease in profit. The company's net worth moved up by a moderate rise of 1.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omics International?
In 2019, Omics International had a promoter holding of 98.37% and a public holding of 1.63%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srinu Sci Technol Biosoft Private LimitedActive 13 years 9 monthsGedela Rao and Anitha Gedela are mutual person
- Omics Entertainment Private LimitedActive 11 years 1 month
Gedela Rao and Anitha Gedela are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 May 2022 | ₹5.00 Cr | Open |
Others Creation Date: 23 Mar 2017 | ₹10.00 Cr | Open |
Canara Bank Creation Date: 21 Aug 2018 | ₹75.00 Cr | Satisfied |
How Many Employees Work at Omics International?
Omics International has a workforce of 734 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omics International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omics International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
